Illumina, Inc. ( ILMN) - Key Metrics
ILMN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $7.58 | $2.18 | $2.10 | $1.75 |
| 2025Q3 | $6.94 | $0.96 | $1.82 | $1.67 |
| 2025Q2 | $6.70 | $1.49 | $1.48 | $1.34 |
| 2025Q1 | $6.55 | $0.82 | $1.51 | $1.26 |
ILMN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 15.40 |
| 2025Q3 | ? | 23.89 |
| 2025Q2 | ? | 16.04 |
| 2025Q1 | ? | 24.07 |
ILMN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.36% | ? |
| 2025Q4 | 1.30% | ? |
| 2025Q3 | 1.85% | ? |
| 2025Q2 | 1.41% | ? |
| 2025Q1 | 1.59% | ? |
ILMN
Price: $170.93
52 week price:
Payout Ratio Range:
Earnings Per Share: 5.49 USD
P/E Ratio: 25.97
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1.1 million
Ebitda: 273.0 millionMarket Capitalization: 21.6 billion